Is a complete HKG/1093 research report available?

Question

Accepted Answer

No complete published report is available for hkg/1093 (HKG/1093) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	94.9B
Revenue (ttm)	28.9B
Net income (ttm)	3.7B
EPS (ttm)	HK$0.33
Shares out	11.4B
P/E (trailing)	25.5x
P/E (forward)	12.0x
Dividend	HK$0.29 (3.39%)
Volume	77,943,718

Metric	Value
Country	Hong Kong
Country code	HK
Employees	19,700
Employees Change	-1,700%
Employees Change Percent	-7.94
Enterprise value	HKD 85.4B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Industry PE	48.94
Isin	HK1093012172
Last refreshed	2026-07-28
Market cap	HKD 94.9B
Price	HKD 8.61
Price currency	HKD
Rev Per Employee	1,468,816.84x
Sector	Healthcare
Sector PE	128.6
Sector PE Fwd	25.58
Sic	2834
Symbol	hkg/1093
Website	https://www.cspc.com.hk

Metric	Value
Earnings Yield	3.91%
EV Earnings	23.02x
EV/EBIT	22.44x
EV/EBITDA	16.04x
EV/FCF	19.04x
EV/Sales	2.95x
FCF yield	4.73%
Forward P/E	12x
P/B ratio	2.42x
P/E ratio	25.53x
P/S ratio	3.28x
PE Ratio10 Y	21.04x
PE Ratio3 Y	15.91x
PE Ratio5 Y	15.6x
PEG ratio	1.77x

Metric	Value
EBIT Margin	13.44%
EBITDA Margin	18.02%
FCF margin	14.89%
Gross margin	65.29%
Gross Profit	HKD 18.9B
Gross Profit Growth	-10.19%
Gross Profit Growth Q	-9.28%
Gross Profit Growth3 Y	-8.87%
Gross Profit Growth5 Y	-2.98%
Net Income	HKD 3.7B
Net Income Growth	-22.16%
Net Income Growth Q	-41.83%
Net Income Growth Years	0%
Net Income Growth3 Y	-18.89%
Net Income Growth5 Y	-9.82%
Pretax Margin	16.29%
Profit Margin	12.82%
Profit Per Employee	HKD 188,325
Profitable Quarters	HKD 47
Profitable Years	23
Roa5y	9.18
ROE	9.57
Roe5y	17.25
ROIC	10.88
Roic5y	25.58

Metric	Value
Cagr10y	11.07%
Cagr15y	12.65%
Cagr1y	-0.16%
Cagr20y	18.22%
Cagr3y	13.81%
Cagr5y	-1.11%
Div CAGR10	17.61%
Div CAGR3	11.36%
Div CAGR5	17.86%
EPS Growth	-20.63
EPS Growth Q	-41.6
EPS Growth Years	0
EPS Growth3 Y	-17.71
EPS Growth5 Y	-8.98
FCF Growth	53.7%
FCF Growth3 Y	-10.53%
FCF Growth5 Y	-6.38%
OCF Growth	28.6%
OCF Growth10 Y	11.96%
OCF Growth3 Y	-8.56%
OCF Growth5 Y	-2.85%
Revenue Growth	-5.86x
Revenue Growth Q	-7.83x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.47x
Revenue Growth5 Y	-0.07x

HKG/1093 (HKG/1093)

Coverage state: Market snapshot only — no published research

Generate the first HKG/1093 analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · HKG/1093

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HKG/1093 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HKG/1093

Frequently asked questions

Metric	Value
Cash	HKD 11.8B
Debt	HKD 728.7M
Debt EBITDA	HKD 0.13
Debt Equity	HKD 0.02
Debt FCF	HKD 0.16
Equity	HKD 39.3B
Interest Coverage	79.79
Net Cash	HKD 11.1B
Net Cash By Market Cap	HKD 11.66
Net Cash Growth	12.77%
Net Debt EBITDA	HKD -2.12
Net Debt Equity	HKD -0.28
Net Debt FCF	HKD -2.47
Tangible Book Value	HKD 34.4B
Tangible Book Value Per Share	HKD 3.01
WACC	8.21

Metric	Value
Buyback Yield	1.93%
Dividend Growth	11.54%
Dividend Growth Years	0%
Dividend per share	HKD 0.29
Dividend Years	14
Dividend Yield	3.39%
Ex Div Date	2026-06-24
Last Dividend	HKD 0.15
Payout Frequency	Semi-Annual
Payout Ratio	89.22%

Metric	Value
10Y total return	185.63%
1Y total return	-0.16%
200-day SMA	8.5
3Y total return	47.42%
50-day SMA	7.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-5.42%
All Time High	13.93
All Time High Change	-40.42%
All Time High Date	2018-05-28
All Time Low	0.22
All Time Low Change	3,695.15%
All Time Low Date	1998-01-12
ATR	0.42
Beta	0.72
Beta1y	0.83
Beta2y	0.44
Ch YTD	-1.54
High	8.65
High52	11.63
High52 Date	2025-09-09
High52ch	-25.97%
Low	8.38
Low52	6.53
Low52 Date	2026-06-25
Low52ch	31.85%
Ma50ch	9.69%
Price vs 200-day SMA	-2.33%
RSI	56.5
RSI Monthly	52.83
RSI Weekly	49.85
Sharpe ratio	0.17x
Sortino ratio	0.38
Total Return	5.33%
Tr YTD	0.67
Tr15y	496.9%
Tr1m	24.07%
Tr1w	-2.35%
Tr3m	-5.5%

Metric	Value
Analyst Count	23
Analyst Count Top	2
Analyst Price Target Top	HKD 11.88
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Operating Income	HKD 3.9B
Operating Income Growth	-29.42
Operating Income Growth Q	-35.68
Operating Income Growth3 Y	-20.05
Operating Income Growth5 Y	-10.62
Operating margin	13.44
Price target	HKD 11.55
Price Target Change	HKD 34.15
Price Target Change Top	HKD 37.98

Metric	Value
Float	7,648,721,946%
Net Borrowing	-168,929,078.8
Shares Insiders	26.49%
Shares Institutions	32.69%
Shares Out	11,433,024,932
Shares Qo Q	-0.01%
Shares Yo Y	-1.93%

Metric	Value
Adjusted FCF	HKD 4.6B
Average Volume	118,442,253.85x
Bv Per Share	3.3
CAPEX	HKD -2.3B
Ch10y	127.6
Ch15y	345
Ch1m	24.07
Ch1w	-2.35
Ch1y	-3.82
Ch20y	1,711
Ch3m	-7.57
Ch3y	30.5
Ch5y	-20.35
Ch6m	-13.54
Change	3.73%
Change From Open	2.26
Close	8.3
Days Gap	1.45
Depreciation Amortization	1,349,647,862.3
Dollar Volume	671,095,412
Earnings Date	2026-08-20
EBIT	HKD 3.9B
EBITDA	HKD 5.2B
EPS	HKD 0.33
F Score	3
FCF	HKD 4.5B
FCF EV Yield	5.25x
FCF Per Share	HKD 0.39
Financing CF	-3,024,314,554.2
Fiscal Year End	December
Founded	1,992
Graham Number	5.00793
Graham Upside	-39.66
Income Tax	HKD 993.1M
Investing CF	-4,490,765,560.8
Is Primary Listing	1
Last Earnings Date	2026-05-27
Last Report Date	2026-03-31
Last Split Date	2020-10-15
Last Split Type	Forward
Lynch Fair Value	HKD 1.62
Lynch Upside	-80.45
Ma150	8.6
Ma150ch	-3.45%
Ma20	8.08
Ma20ch	2.79%
Net CF	-767,612,900.2
Next Earnings Date	2026-08-20
Open	8.42
P FCF Ratio	21.16
P OCF Ratio	14.05
Payment Date	2026-07-15
Position In Range	85.19
Price Date	2026-07-28
Price EBITDA	HKD 18.2
Ptbv Ratio	2.76
Relative Volume	0.66x
Revenue	28,935,691,763x
SBC By Revenue	-0.25x
Share Based Comp	-76,367,801.5
Tax By Revenue	3.43x
Tax Rate	21.07%
Tr20y	2,741.57%
Tr6m	-11.6%
Volume	77,943,718